IPEX and FOXP3:: Clinical and research perspectives

被引:103
|
作者
Wildin, RS [1 ]
Freitas, A [1 ]
机构
[1] Inst Pasteur, CNRS, Unite Biol Populat Lymphocytaires, URA 1961, F-75724 Paris 15, France
关键词
cell-based therapy; gene therapy; imprinting; T regulatory cells; X inactivation;
D O I
10.1016/j.jaut.2005.04.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome is a rare inborn error of immune regulation characterized by the early onset of one or more autoimmune diseases in boys. IPEX is caused by mutations in FOXP3, and is thus the homologue of the scurfy mutant mouse. The gene product, Scurfin, is required for the development of CD4 + CD25 + T regulatory cells. In the absence of T regulatory cells, activated CD4 + T cells instigate multi-organ damage resulting in type 1 diabetes, enteropathy, eczema, hypothyroidism, and other autoimmune disorders. While effective therapies are currently limited, studies in the scurfy mouse are revealing aspects of pathophysiology and genetics that will lead to novel approaches for treating IPEX and other autoimmune disorders. Females carrying Foxp3 mutations are unaffected. In new experiments we show that female scurfy mice that are also heterozygous in trans for the X-linked recessive common gamma chain knockout contract autoimmune disease, proving that murine Foxp3 is subject to X-mactivation and providing an example of gene-gene interaction causing autoimmune disease in females. One explanation for the lesser disease severity in these females is proposed. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:56 / 62
页数:7
相关论文
共 50 条
  • [1] IPEX as a result of Mutations in FOXP3
    van der Vliet, Hans J. J.
    Nieuwenhuis, Edward E.
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2007,
  • [2] IPEX as a Consequence of Alternatively Spliced FOXP3
    Mailer, Reiner K.
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [3] The Spectrum of FOXP3 Gene Mutations and Clinical Features in IPEX Syndrome
    Knight, C. M.
    Gambineri, E.
    Hackett, M.
    Anover-Sombke, S.
    Ochs, H.
    Torgerson, T.
    CLINICAL IMMUNOLOGY, 2010, 135 (02) : 287 - 288
  • [4] IPEX and 'IPEX-Like' Syndrome: FOXP3 and Related Pathway
    Mannurita, Sara Ciullini
    Vignoli, Marina
    Bacchetta, Rosa
    Cecconi, Massimiliano
    Tommasini, Alberto
    Gennery, Andrew R.
    Cant, Andrew J.
    Gambineri, Eleonora
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (03) : 365 - 365
  • [5] Mutations of FOXP3 causing IPEX syndrome.
    Gambineri, E
    Torgerson, TR
    Bennett, CL
    Amoroso, A
    Barker, DF
    Cunningham-Rundles, C
    Notarangelo, L
    Ronchetti, R
    Sakiyama, Y
    Ochs, HD
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S139 - S140
  • [6] IPEX with normal FOXP3 gene and diminished expression
    Solomon, M
    Ochs, H
    Hostoffer, R
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S290 - S290
  • [7] A CASE OF IPEX SYNDROME WITH FOXP3 MISSENSE MUTATION
    Schroeder, N. D.
    Stallings, A.
    Saulsbury, F.
    Heymann, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A91 - A91
  • [8] IPEX Syndrome in Siblings with a Novel Variant in FOXP3
    Hines, Brittany
    Wright, Benjamin L.
    Wadera, Sheetal
    Cac, Natalie
    Miller, Holly K.
    Abraham, Roshini S.
    Bauer, Cindy S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB118 - AB118
  • [9] IPEX and the role of FOXP3 in the development and function of human Tregs
    Le Bras, Severine
    Geha, Raif S.
    JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (06): : 1473 - 1475
  • [10] IPEX syndrome with normal FOXP3 coding region sequences but diminished FOXP3 transcription and translation: An implied FOXP3 regulatory gene defect.
    Schaffer, Frederick
    Cochran, Joe
    Key, L.
    Chatila, Total
    Anover, S.
    Hockett, M.
    Ochs, Hans
    Torgerson, Troy
    CLINICAL IMMUNOLOGY, 2006, 119 : S131 - S132